A phase III clinical trial of ZD1839 (Iressa) in combination with gemcitabine and cisplatin in chemo-naive patients with advanced non-small cell lung cancer (INTACT 1)
収録刊行物
-
- Ann Oncol
-
Ann Oncol 13 2-3, 2002